Acute Coronary Syndromes research hub

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

This study looks at a new drug, Orticumab, to see if it can reduce inflammation in the heart's arteries after a heart attack. Researchers will compare it to a dummy drug (placebo) over 6 months to see its effects.